Conference News Conference News Daily digests from key neurology conferences, written by on-site medical journalists. Published: Jun 14, 2020

PAR2 may represent a novel target for migraine prevention

Results presented at AHS 2020 suggest that PAR2 blockade using a monoclonal antibody may prevent downstream mechanisms related to migraine and may provide an additional anti-migraine strategy.